Among patients with COPD at low risk for exacerbations, prescription of inhaled corticosteroids was associated with patient complexity, study results published in the Annals of the American Thoracic Society suggest.

Recently, evidence has fueled concerns that inhaled corticosteroids may be overused in COPD and, therefore, of “low value,” according to the researchers.